Lexington, MA, United States of America

Jungyeon Hwang

This inventor holds 2 USPTO granted patents and 14 published patent applications. Top assignees: Ceruliean Pharma Inc., Other. Active years: 2013-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jungyeon Hwang. Retrieved from https://idiyas.com/inventor/jungyeon-hwang-osf9kyib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jungyeon Hwang: Innovator in Controlled Drug Delivery

Introduction

Jungyeon Hwang is a notable inventor based in Lexington, MA (US), recognized for his contributions to the field of drug delivery systems. With a total of 2 patents to his name, Hwang has made significant strides in developing innovative therapeutic solutions.

Latest Patents

Hwang's latest patents include "Polymer drug conjugates with tether groups for controlled drug delivery" and "Cyclodextrin-based polymers for therapeutics delivery." The first patent describes a cyclodextrin-containing polymer conjugate designed for controlled drug delivery. The second patent relates to novel compositions that involve polymeric moieties covalently attached to therapeutic agents, allowing for targeted delivery through various tether groups and ligands. These inventions present methods for effectively treating subjects with the described therapeutic compositions.

Career Highlights

Throughout his career, Jungyeon Hwang has worked with various companies, including Cerulean Pharma Inc. His work has focused on advancing drug delivery technologies, which are crucial for improving patient outcomes in therapeutic applications.

Collaborations

Hwang has collaborated with notable professionals in his field, including Mark E. Davis and Tianyi Ke. These collaborations have contributed to the development of innovative solutions in drug delivery.

Conclusion

Jungyeon Hwang's work in controlled drug delivery exemplifies the impact of innovation in the medical field. His patents and collaborations highlight his commitment to advancing therapeutic technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…